Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thrombelastographic pattern recognition in renal disease and trauma.
Chapman MP, Moore EE, Burneikis D, Moore HB, Gonzalez E, Anderson KC, Ramos CR, Banerjee A. Chapman MP, et al. Among authors: anderson kc. J Surg Res. 2015 Mar;194(1):1-7. doi: 10.1016/j.jss.2014.12.012. Epub 2014 Dec 10. J Surg Res. 2015. PMID: 25577141 Free PMC article.
Single-cell RNA sequencing reveals unique monocyte-derived interstitial macrophage subsets during lipopolysaccharide-induced acute lung inflammation.
Moore PK, Anderson KC, McManus SA, Tu TH, King EM, Mould KJ, Redente EF, Henson PM, Janssen WJ, McCubbrey AL. Moore PK, et al. Among authors: anderson kc. Am J Physiol Lung Cell Mol Physiol. 2023 Apr 1;324(4):L536-L549. doi: 10.1152/ajplung.00223.2022. Epub 2023 Feb 28. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 36852927 Free PMC article.
PTPα promotes fibroproliferative responses after acute lung injury.
Aschner Y, Correll KA, Beke KM, Foster DG, Roybal HM, Nelson MR, Meador CL, Strand M, Anderson KC, Moore CM, Reynolds PR, Kopf KW, Burnham EL, Downey GP. Aschner Y, et al. Among authors: anderson kc. Am J Physiol Lung Cell Mol Physiol. 2022 Jul 1;323(1):L69-L83. doi: 10.1152/ajplung.00436.2021. Epub 2022 Jun 7. Am J Physiol Lung Cell Mol Physiol. 2022. PMID: 35670474 Free PMC article.
MicroRNA-126-3p Inhibits Angiogenic Function of Human Lung Microvascular Endothelial Cells via LAT1 (L-Type Amino Acid Transporter 1)-Mediated mTOR (Mammalian Target of Rapamycin) Signaling.
Cao D, Mikosz AM, Ringsby AJ, Anderson KC, Beatman EL, Koike K, Petrache I. Cao D, et al. Among authors: anderson kc. Arterioscler Thromb Vasc Biol. 2020 May;40(5):1195-1206. doi: 10.1161/ATVBAHA.119.313800. Epub 2020 Mar 26. Arterioscler Thromb Vasc Biol. 2020. PMID: 32212853 Free PMC article.
Protein tyrosine phosphatase-α amplifies transforming growth factor-β-dependent profibrotic signaling in lung fibroblasts.
Aschner Y, Nelson M, Brenner M, Roybal H, Beke K, Meador C, Foster D, Correll KA, Reynolds PR, Anderson K, Redente EF, Matsuda J, Riches DWH, Groshong SD, Pozzi A, Sap J, Wang Q, Rajshankar D, McCulloch CAG, Zemans RL, Downey GP. Aschner Y, et al. Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L294-L311. doi: 10.1152/ajplung.00235.2019. Epub 2020 Jun 3. Am J Physiol Lung Cell Mol Physiol. 2020. PMID: 32491951 Free PMC article.
A plain language summary of the ICARIA study, comparing isatuximab-pomalidomide- dexamethasone with pomalidomide- dexamethasone in people with multiple myeloma.
Richardson PG, Perrot A, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang SY, Minarik J, Cavo M, Prince HM, Anderson KC. Richardson PG, et al. Among authors: anderson kc. Future Oncol. 2025 Jan 24:1-11. doi: 10.1080/14796694.2025.2449781. Online ahead of print. Future Oncol. 2025. PMID: 39851267
Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma.
Waldschmidt JM, Sotudeh N, Arora S, Vijaykumar T, Anand P, Stuart H, Frede J, Campbell TB, Kaiser S, Zheng X, Munshi NC, Anderson KC, Einsele H, Yee AJ, Knoechel B, Lohr JG, Raje NS. Waldschmidt JM, et al. Among authors: anderson kc. Blood Adv. 2025 Jan 15:bloodadvances.2024015285. doi: 10.1182/bloodadvances.2024015285. Online ahead of print. Blood Adv. 2025. PMID: 39813623
Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trial.
Nadeem O, Aranha MP, Redd R, Timonian M, Magidson S, Lightbody ED, Alberge JB, Bertamini L, Dutta AK, El-Khoury H, Bustoros M, Laubach JP, Bianchi G, O'Donnell E, Wu T, Tsuji J, Anderson KC, Getz G, Trippa L, Richardson PG, Sklavenitis-Pistofidis R, Ghobrial IM. Nadeem O, et al. Among authors: anderson kc. Nat Commun. 2025 Jan 3;16(1):358. doi: 10.1038/s41467-024-55308-5. Nat Commun. 2025. PMID: 39753553 Free PMC article. Clinical Trial.
1,230 results